The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(beta-D-2-deoxyribofuranosyl)-10-methyl-1,3-diaza-2-oxophenoxazine ID: ALA4873641
PubChem CID: 164620757
Max Phase: Preclinical
Molecular Formula: C16H17N3O5
Molecular Weight: 331.33
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1c2ccccc2Oc2cn([C@H]3C[C@H](O)[C@@H](CO)O3)c(=O)nc21
Standard InChI: InChI=1S/C16H17N3O5/c1-18-9-4-2-3-5-11(9)23-12-7-19(16(22)17-15(12)18)14-6-10(21)13(8-20)24-14/h2-5,7,10,13-14,20-21H,6,8H2,1H3/t10-,13+,14+/m0/s1
Standard InChI Key: URQLGQUGFZFHGV-ZLKJLUDKSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
21.4065 -10.4336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4054 -11.2531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8202 -10.4300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1116 -10.0247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8231 -11.2527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1122 -11.6632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1122 -12.4795 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.5340 -11.6585 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5324 -12.4811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8209 -12.8946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8232 -13.7130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5354 -14.1241 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.2469 -13.7106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2463 -12.8860 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5365 -14.9413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8757 -15.4239 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.1294 -16.2008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9466 -16.1996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1979 -15.4220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6500 -16.8626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9834 -17.6086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.9554 -14.1180 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.4279 -16.8600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2411 -11.2489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 6 1 0
5 3 1 0
3 4 2 0
4 1 1 0
5 6 2 0
5 8 1 0
6 7 1 0
7 10 1 0
9 8 1 0
9 10 1 0
9 14 2 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 1 0
15 12 1 1
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 15 1 0
17 20 1 1
20 21 1 0
13 22 2 0
18 23 1 6
8 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 331.33Molecular Weight (Monoisotopic): 331.1168AlogP: 0.76#Rotatable Bonds: 2Polar Surface Area: 97.05Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.89CX Basic pKa: ┄CX LogP: 0.04CX LogD: 0.04Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.84Np Likeness Score: 0.46
References 1. Kozlovskaya LI, Volok VP, Shtro AA, Nikolaeva YV, Chistov AA, Matyugina ES, Belyaev ES, Jegorov AV, Snoeck R, Korshun VA, Andrei G, Osolodkin DI, Ishmukhametov AA, Aralov AV.. (2021) Phenoxazine nucleoside derivatives with a multiple activity against RNA and DNA viruses., 220 [PMID:33894564 ] [10.1016/j.ejmech.2021.113467 ]